Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis

Annales de Biologie Clinique

Volumn 66, Issue 6, 2008, Pages 621-629

  Pongnimitprasert, N ^a,b   El Benna, J ^a   Foglietti, M J ^b   Gougerot Pocidalo, M A ^a,c   Bernard, M ^b,d   Braut Boucher, F ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cystic fibrosis; General review; NADPH oxidases; Reactive oxygen species

Indexed keywords

DUOX1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NOX5 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

COMPARATIVE STUDY; CYSTIC FIBROSIS; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; NADPH OXIDASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 58149390317     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2008.0285     Document Type: Review

References (42)

1. Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev 1999; 79: S215-55.
2. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respiry Crit Care Med 2003; 168: 918-51.
3. Sumimoto H, Ueno N, Yamasaki T, et al. Molecular mechanism underlying activation of superoxide-producing NADPH oxidases : Roles for their regulatory proteins. Jpn J Infect Dis 2004; 57: S24-5.
4. Bedar K, Krause KH, The NOX. Family of ROS-Generating NADPH oxidases : Physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
5. Poschet J, Perkett E, Deretic V. Hyperacidification in cystic fibrosis: g disease and new prospects for treatment. Trends Mol Med 2002; 8: 512-9.
6. El-Benna J, Dang PMC, Gougerot-Pocidalo MA, et al. Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses. Arch Immunol Ther Exp 2005; 53: 199-206.
7. Elbim C, Bailly S, Chollet-Martin S, et al. Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides. Infect Immun 1994; 62: 2195-201.
8. El-Benna J, Dang PMC, Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation : Role of P47PHOX phosphorylation and NOX 2 translocation. Semin Immunol 2008 (In Press).
9. Geiszt M, Witta J, Baffi J, et al. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J 2003; 17: 1502-4.
10. Schwarzer C, Machen TE, Illek B, et al. NADPH Oxidase dependent acid production in airway epithelial cells. J Biol Chem 2004; 279: 36545-61.
11. Schneider M, Hirt C, Casaulta C, et al. Large deletions in the CFTR gene : clinics and genetics in Swiss patients with CF. Clin Genet 2007; 72: 30-8.
12. Kiechle FL, Holland-Staley CA. Genomics, transcriptomics, proteomics, and numbers. Arch Pathol Lab Med 2003; 127: 1089-95.
13. Tirouvanziam R. Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis. Drug News Prospect 2006; 19: 609-14.
14. Tager AM, Wu J, Vermeulen MW. The effect of chloride concentration on human neutrophil functions : potential relevance to cystic fibrosis. Am J Respir Cell Mol Biol 1998; 19: 643-52.
15. Coakley RD, Grubb BR, Paradiso AM, et al. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci USA 2003; 100: 16083-8.
16. Kettle AJ, Chan T, Osberg I, et al. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 2004; 170: 1317-23.
17. Mayer-Hamblett N, Ramsey BW, Kronmal RA. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thor Soc 2007; 4: 370-7.
18. Pitt BR. CFTR trafficking and signaling in respiratory epithelium. Am J Physiol Lung Cell Mol Physiol 2001; 281: 13-5.
19. Powell K, Zeitlin PL. Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targeting. Adv Drug Deliv Rev 2002; 54: 1395-408.
20. Mishra A, Greaves R, Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 2005; 26: 135-53.
21. Griese M, Ramakers J, Krasselt A, et al. G. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 822-8.
22. Terheggen-Lagro SWJ, Rijkers GT, Ent van de CK. The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis. J Cyst Fibr 2005; 4: 15-23.
23. Owen CA. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc Am Thor Soc 2005; 2: 373-85.
24. Babior BM. NADPH oxidase : an update. Blood 1999; 93: 1464-76.
25. 2+-activated NADPH oxidase in testis, spleen, and Lymph nodes. J Biol Chem 2001; 276: 37594-601.
26. phox are dominant inhibitors of NOX1- and NOX2-dependent reactive oxygen generation. J Biol Chem 2005; 280: 31859-69.
27. phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 2003; 278: 25234-46.
28. Bokoch GM, Knaus UG. NADPH oxidases: not just for leukocytes anymore! Trends Biochem Sci 2003; 28: 502-9.
29. Krause KH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn J Infect Dis 2004; 57: S28-9.
30. 2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol 2006; 26: 140-54.
31. Ueyama T, Geiszt M, Leto TL. Involvement of Rac1 in activation of multicomponent NOX1- and NOX3-based NADPH oxidases. Mol Cell Biol 2006; 26: 2160-74.
32. Orient A, Donko A, Szabó A, et al. Novel sources of reactive oxygen species in the human body. Nephrol Dial Transplant 2007: 1-8.
33. Bandyopadhyay U, Das D, Banerjee RK. Reactive oxygen species: Oxidative damage and pathogenesis. Curr Sci 1999; 77: 658-66.
34. Israël N, Gougerot-Pocidalo MA, Aillet F, et al. Redox status of cells influences constitutive or induced NF-kappaB translocation and HIV long terminal repeat activity in human T and monocyte cell lines. J Immunol 1992; 149: 3386-93.
35. Gougerot-Pocidalo MA, Aillet F, Virelizier JL, et al. Influence of redox status of lymphocytes and monocytes on HIV transcription and replication. Immunobiology 1995; 193: 204-9.
36. Gozin A, Franzini E, Andrieu V, et al. Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells. Free Radic Biol Med 1998; 25: 1021-32.
37. Schmid E, El Benna J, Galter D, et al. Redox priming of the insulin receptor beta-chain associated with altered tyrosine kinase activity and insulin responsiveness in the abscence of tyrosine autophosphorylation. FASEB J 1998; 12: 863-70.
38. Elbim C, Chollet-Martin S, Bailly S, et al. Priming of polymorphonuclear neutrophils by tumor necrosis factor alpha in whole blood : identification of two polymorphonuclear subpopulations in response to formyl-peptides. Blood 1993; 15: 633-40.
39. Jacquot J, Tabary O, Le Rouzic P, et al. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int J Biochem Cell Biol 2008; 40: 1703-15.
40. Matt X, Shao MX, Nadel JA. Dual oxidase 1- dependent MUC5A5 mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 2005; 102: 767-72.
41. Yan F, Li W, Jono H, et al. Reactive oxygen species regulate Pseudomonas aeruginosa LPS induced MUC5AC mucin expression via PKC-NADPH oxidase-ROS-TGF6alpha signalling pathways in human epithelial cells. Biochem Biophysic Res Commun 2008; 366: 513-9.
42. Moska P, Lorentzen D, Excoffon KJ, et al. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 2007; 175: 174-83.